Consolidated Income Statements - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Net sales	$ 4,917	$ 4,873	$ 19,383	$ 19,831
Cost of goods sold	3,090	3,084	11,322	11,703
Other operating charges	176	91	504	413
Selling, general and administrative expenses	1,016	1,046	3,355	3,540
Research and development expense	410	441	1,260	1,415
Other (loss) income, net	(16)	98	407	552
Interest expense	93	82	278	260	[1]
Employee separation / asset related charges, net	172	0	159	40
(Loss) income from continuing operations before income taxes	(56)	227	2,912	3,012
(Benefit from) provision for income taxes on continuing operations	(69)	96	643	886
Income from continuing operations after income taxes	13	131	2,269	2,126
(Loss) income from discontinued operations after income taxes	(7)	104	(7)	89
Net income	6	235	2,262	2,215
Less: Net income attributable to noncontrolling interests	4	0	14	9
Net income attributable to DuPont	$ 2	$ 235	$ 2,248	$ 2,206
Basic earnings per share of common stock from continuing operations	$ 0.01	$ 0.14	$ 2.57	$ 2.34
Basic (loss) earnings per share of common stock from discontinued operations	(0.01)	0.12	(0.01)	0.10
Basic earnings per share of common stock	0.00	0.26	2.56	2.44
Diluted earnings per share of common stock from continuing operations	0.01	0.14	2.56	2.33
Diluted (loss) earnings per share of common stock from discontinued operations	(0.01)	0.12	(0.01)	0.10
Diluted earnings per share of common stock	0.00	0.26	2.55	2.43
Dividends per share of common stock	$ 0.38	$ 0.38	$ 1.14	$ 1.34

[1] Includes transaction costs of $(20) in the nine months ended September 30, 2015, associated with the early retirement of debt exchanged for the notes received from Chemours in May 2015. These costs were recorded in interest expense in the company's interim Consolidated Income Statements. See Note 3 for additional information.